GC Cell Balance Sheet Health
Financial Health criteria checks 2/6
GC Cell has a total shareholder equity of ₩525.1B and total debt of ₩60.1B, which brings its debt-to-equity ratio to 11.4%. Its total assets and total liabilities are ₩656.9B and ₩131.8B respectively.
Key information
11.4%
Debt to equity ratio
₩60.06b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩10.48b |
| Equity | ₩525.10b |
| Total liabilities | ₩131.77b |
| Total assets | ₩656.87b |
Recent financial health updates
Is GC Cell (KOSDAQ:144510) A Risky Investment?
Sep 08
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Recent updates
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price
Oct 14Is GC Cell (KOSDAQ:144510) A Risky Investment?
Sep 08We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative
Mar 19We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt
Feb 22Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?
Jan 18
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?
Dec 14Financial Position Analysis
Short Term Liabilities: A144510's short term assets (₩66.8B) do not cover its short term liabilities (₩86.0B).
Long Term Liabilities: A144510's short term assets (₩66.8B) exceed its long term liabilities (₩45.7B).
Debt to Equity History and Analysis
Debt Level: A144510's net debt to equity ratio (9.4%) is considered satisfactory.
Reducing Debt: A144510's debt to equity ratio has increased from 9.4% to 11.4% over the past 5 years.
Debt Coverage: A144510's debt is not well covered by operating cash flow (2.8%).
Interest Coverage: Insufficient data to determine if A144510's interest payments on its debt are well covered by EBIT.